COX-2 Inhibitors

  • Michel Pairet
  • Joanne van Ryn

Part of the Milestones in Drug Therapy MDT book series (MDT)

Table of contents

  1. Front Matter
    Pages I-X
  2. Regina M. Botting, Jack H. Botting
    Pages 1-13
  3. Lawrence J. Marnett, Amit S. Kalgutkar
    Pages 15-40
  4. Guenter Trummlitz, Joanne van Ryn, Timothy D. Warner
    Pages 41-65
  5. Joanne van Ryn, Michel Pairet
    Pages 149-160
  6. Rahul Nayak, Brendan F. McAdam
    Pages 161-178
  7. Dirk O. Stichtenoth
    Pages 179-194
  8. R. Stokes Peebles Jr., Koichi Hashimoto
    Pages 195-212
  9. Aarthi R. Mohan, Phillip R. Bennett
    Pages 213-225
  10. Kirsi Saukkonen, Christianne J. Buskens, Anna Sivula, Bastiaan P. van Rees, Tiina-Liisa Erkinheimo, Johanna Rintahaka et al.
    Pages 227-243
  11. Back Matter
    Pages 245-250

About this book


COX-2 inhibitors are important drugs with analgesic and anti-inflammatory effects. The discovery of COX-2, the evolution of drug development in this field and the implications of these developments in patient therapy are topics of this volume. This book presents both pre-clinical and clinical information and is important for clinicians interested in the latest information about this class of drugs, for researchers and for students in the field.


Alzheimer NSDAIDSs alzheimer's disease analgesic effects cancer cardiovascular system development drug drug development evolution kidney pharmacology reproduction research ulcer

Editors and affiliations

  • Michel Pairet
    • 1
  • Joanne van Ryn
    • 2
  1. 1.Department of Pulmonary ResearchBoehringer Ingelheim Pharma GmbH & Co. KGBiberach a. d. RissGermany
  2. 2.Department Drug Discovery SupportBoehringer Ingelheim Pharma GmbH & Co. KGBiberach a. d. RissGermany

Bibliographic information